Application 202160

Type
ANDA
Sponsor
AUROLIFE PHARMA LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OXYCODONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDETABLET;ORAL5MGNoNo
002OXYCODONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDETABLET;ORAL15MGNoNo
003OXYCODONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDETABLET;ORAL30MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
13107-055Oxycodone HydrochlorideOxycodone HydrochlorideAurolife Pharma, LLCANDACurrent
13107-055Oxycodone HydrochlorideOxycodone HydrochlorideAurolife Pharma, LLCANDACurrent
13107-056Oxycodone HydrochlorideOxycodone HydrochlorideAurolife Pharma, LLCANDACurrent
13107-056Oxycodone HydrochlorideOxycodone HydrochlorideAurolife Pharma, LLCANDACurrent
13107-057Oxycodone HydrochlorideOxycodone HydrochlorideAurolife Pharma, LLCANDACurrent
13107-057Oxycodone HydrochlorideOxycodone HydrochlorideAurolife Pharma, LLCANDACurrent
68071-2368Oxycodone HydrochlorideOxycodone HydrochlorideNuCare Pharmaceuticals,Inc.ANDACurrent
71335-1361Oxycodone HydrochlorideOxycodone HydrochlorideBryant Ranch PrepackANDACurrent
71335-1361Oxycodone HydrochlorideOxycodone HydrochlorideBryant Ranch PrepackANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
76329ORIG 2023-11-03